Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 16 of 16 for “"17-DMAG"”.
-
Inhibition of Heat Shock Protein 90 Reduces Inflammatory Signal Transduction in Murine J774 Macrophage Cells and Lessens Disease in Autoimmune MRL/lpr Mice: What in vitro, in vivo, and in silico Models Reveal
… such as geldanamycin (GA) and its derivative 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) have been shown to reduce inflammation. It was hypothesized that inhibiting HSP90 would reduce inflammatory signal cascade levels. To test this, J774 mouse macrophage cells were treated …
-
Inhibition of Hsp90 and its Client Kinase FAK has Therapeutic Potential in Squamous Cell Carcinomas of the Uterine Cervix and Oral Cavity
… was seen with the geldanamycin derivative 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG). Importantly, focal adhesion kinase (FAK) signaling and associated functional parameters were inhibited by the drug treatment. Functional significance of FAK as a client was confirmed …
-
INHIBITION OF HSP90 IN TRYPANOSOMA BRUCEI AND PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS OF ANTITRYPANOSOMALS
… studies of geldanamycin analogs found 17-AAG and 17-DMAG were most selective against T. brucei compared to mammalian cells. Both oral and parenteral 17-DMAG cured mice of a normally lethal infection of T. brucei. 17-AAG treatment sensitized trypanosomes to heat shock and caused severe …
-
Mitigating cisplatin resistance in ovarian cancer.
… cells. Co-treatment with HSP90 inhibitor 17-DMAG plus CPA 39°C greatly sensitized EOC cells by enhancing cellular platinum accumulation. In order to translate the in vitro findings in an in vivo model, metastatic ovarian cancer was established in nude mice by intraperitoneal injection of …
-
Investigating the Roles SAFB Proteins Play in Controlling Haemopoiesis and in Acute Lymphoblastic Leukaemia
… of anti-cancer HSP90 inhibitors (celastrol and 17-DMAG) has been characterised in ALL cells. Experiments to characterise the ALL stress response found that HSF1 was constitutively overexpressed and HSF1 nuclear border expression was present in primary BCP-ALL and T-ALL cells following heat shock …
-
Searching for therapeutic strategies in a mouse modelo of Machado-Joseph disease: targeting proteostases
… (i) molecular chaperone load, (Hsp90 inhibitor - 17-dimethyl aminoethylamino-17-demethoxygeldanamycin hydrochloride - 17-DMAG); (ii) autophagy (lithium chloride and a combination of lithium chloride – LiCl - and temsirolimus - CCI-779); (iii) Endoplasmic reticulum (ER) stress response, …
-
Targeting Retinoblastoma tumour suppressor deficiency in Leiomyosarcoma
… behind the cytotoxicity of alvespimycin (17-DMAG) in RB1-deficient LMS cells. Data were validated by western blot analysis and flow cytometry, resulting in the proposal of a model wherein targeting Rb loss engaged with a unique dependency on HSP90 for cell survival.</p> <p>The …
-
Glucocorticoid resistance in childhood B-Cell precursor acute lymphoblastic leukaemia
… resistance. Testing of the HSP90 inhibitor 17-DMAG demonstrated a moderate degree of synergy with dexamethasone in 3 PPR xenografts tested in vitro, but no synergy in vivo, potentially due to the toxicity of the vehicle to the mice. Glucocorticoid resistance in ALL can potentially be …
-
The Role of Cancer Associated Fibroblasts in Bone Invasive Oral Squamous Cell Carcinoma
… attenuated by the senolytic drugs Alvespimycin (17-DMAG) and Navitoclax (ABT263). Moreover, to understand the mechanism by which OSCC and surrounding CAF communicate in the tumour microenvironment, EV were isolated from H357 oral cancer cell line, primary CAF from fresh OSCC tissue and …
-
KRAS mutations of the lung adenocarcinoma genome and their impact on inflammation
… (MC38) und des malignen Pleuramesothelioms (AE17), die potente Induktoren des MPE sind, mutierte Kras-Allele, nicht-kanonische Nuklearfaktor (NF)-κB Aktivierung, die durch Inhibitor der NF-κΒ Kinase α (IKKα) vermittelt wird, Überexpression von proinflammatorischen Chemokinen und die Fähigkeit …
-
Cerebral/pulmonary axis following traumatic brain injury in a preclinical model
… In an attempt to reduce pulmonary injury, 17-DMAG, an HSP90 inhibitor, was applied but proved to be nonprotective. Since patients with TBI show increased susceptibility to bacterial infection, microaspiration and ventilator-induced lung injury, a double-hit model was established whereby …
-
Investigation of dual Src/c-Abl tyrosine kinase inhibition as a novel therapeutic approach for chronic lymphocytic leukaemia
… Notably, CLL cells known to contain the 17p deletion, resulting in p53 dysfunction, responded similarly to other samples. Apoptosis induced by dasatinib involved loss of mitochondrial membrane potential and was caspase-dependent. Although dasatinib treatment alone rarely induced apoptosis …
-
Targeting mutant p53 in cSCCs
… human keratinocytes (NHK). HSP90 inhibitors, 17-AAG and 17-DMAG, reduce mutant p53 protein levels suggesting that HSP90 plays a role in stabilising mutant p53 in cSCCs.<br/><br/>5. PR-619, a broad range deubiquitinating enzyme (DUB) inhibitor, reduces mutant p53 protein levels in a range of …
-
Entwicklung neuartiger pharmakologischer Wirkstoffe als Inhibitoren des HSF-1/HSP70-Systems zur Behandlung des Multiplen Myeloms
… Größenordnung wie die der Positiv-Kontrolle 17-Dimethoxyaminoethylamino-17-demethoxygeldanamycin (17-DMAG, 4b). 4) Ausgangspunkt für die Entwicklung neuartiger HSP70-Inhibitoren war das Ergebnis eines virtuellen Screenings (AG Sotriffer), das darauf abzielte die Proteinfunktion durch eine …
-
Heat Shock Protein 90, a Potential Biomarker for Type I Diabetes: Mechanisms of Release from Pancreatic Beta Cells
Heat shock protein (HSP) 90 is a molecular chaperone that regulates diverse cellular processes by facilitating activities of various protein clients. Recent studies have shown serum levels of the alpha cytoplasmic HSP90 isoform are elevated in newly diagnosed type I diabetic patients, thus …
-
Hsp90 Regulates the NLRP3 Inflammasome via the NF-kB Signaling Pathway
… protein-protein interactions. Treatment with DMAG, an Hsp90 inhibitor, blocked canonical NLRP3 function in differentiated THP-1 immune cells. However, we found no evidence that Hsp90-SGT1 was involved in protein-protein interactions with NLRP3. Instead, experiments revealed that DMAG …